Leah P Dickstein1, Jeih-San Liow1, Alison Austermuehle2, Sami Zoghbi1, Sara K Inati3, Kareem Zaghloul4, Paolo Zanotti-Fregonara1, William H Theodore2. 1. Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland. 2. Clinical Epilepsy Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. 3. EEG Section, OCD, National Institute of Neurological Disorders and Stroke, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. 4. Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Abstract
OBJECTIVES: Neuroinflammation, implicated in epilepsy, can be imaged in humans with positron emission tomography (PET) ligands for translocator protein 18 kDa (TSPO). Previous studies in patients with temporal lobe epilepsy and mesial temporal sclerosis found increased [11C]PBR28 uptake ipsilateral to seizure foci. Neocortical foci present more difficult localization problems and more variable underlying pathology. METHODS: We studied 11 patients with neocortical seizure foci using [11C]PBR28 or [11C] N,N-diethyl-2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide (DPA) 713, and 31 healthy volunteers. Seizure foci were identified with structural magnetic resonance imaging (MRI) and ictal video-electroencephalography (EEG) monitoring. Six patients had surgical resections; five had focal cortical dysplasia type 2A or B and one microdysgenesis. Brain regions were delineated using FreeSurfer and T1-weighted MRI. We measured brain radioligand uptake (standardized uptake values [SUVs]) in ipsilateral and contralateral regions, to compare calculated asymmetry indices [AIs; 200% *(ipsilateral - contralateral)/(ipsilateral + contralateral)] between epilepsy patients and controls, as well as absolute [11C]PBR28 binding as the ratio of distribution volume to free fraction (VT /fP ) in 9 patients (5 high affinity and 4 medium affinity binders) and 11 age-matched volunteers (5 high-affinity and 6 medium affinity) who had metabolite-corrected arterial input functions measured. RESULTS: Nine of 11 patients had AIs exceeding control mean 95% confidence intervals in at least one region consistent with the seizure focus. Three of the nine had normal MRI. There was a nonsignificant trend for patients to have higher binding than volunteers both ipsilateral and contralateral to the focus in the group that had absolute binding measured. SIGNIFICANCE: Our study demonstrates the presence of focal and distributed inflammation in neocortical epilepsy. There may be a role for TSPO PET for evaluation of patients with suspected neocortical seizure foci, particularly when other imaging modalities are unrevealing. However, a complex method, inherent variability, and increased binding in regions outside seizure foci will limit applicability. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
OBJECTIVES: Neuroinflammation, implicated in epilepsy, can be imaged in humans with positron emission tomography (PET) ligands for translocator protein 18 kDa (TSPO). Previous studies in patients with temporal lobe epilepsy and mesial temporal sclerosis found increased [11C]PBR28 uptake ipsilateral to seizure foci. Neocortical foci present more difficult localization problems and more variable underlying pathology. METHODS: We studied 11 patients with neocortical seizure foci using [11C]PBR28 or [11C]N,N-diethyl-2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide (DPA) 713, and 31 healthy volunteers. Seizure foci were identified with structural magnetic resonance imaging (MRI) and ictal video-electroencephalography (EEG) monitoring. Six patients had surgical resections; five had focal cortical dysplasia type 2A or B and one microdysgenesis. Brain regions were delineated using FreeSurfer and T1-weighted MRI. We measured brain radioligand uptake (standardized uptake values [SUVs]) in ipsilateral and contralateral regions, to compare calculated asymmetry indices [AIs; 200% *(ipsilateral - contralateral)/(ipsilateral + contralateral)] between epilepsypatients and controls, as well as absolute [11C]PBR28 binding as the ratio of distribution volume to free fraction (VT /fP ) in 9 patients (5 high affinity and 4 medium affinity binders) and 11 age-matched volunteers (5 high-affinity and 6 medium affinity) who had metabolite-corrected arterial input functions measured. RESULTS: Nine of 11 patients had AIs exceeding control mean 95% confidence intervals in at least one region consistent with the seizure focus. Three of the nine had normal MRI. There was a nonsignificant trend for patients to have higher binding than volunteers both ipsilateral and contralateral to the focus in the group that had absolute binding measured. SIGNIFICANCE: Our study demonstrates the presence of focal and distributed inflammation in neocortical epilepsy. There may be a role for TSPO PET for evaluation of patients with suspected neocortical seizure foci, particularly when other imaging modalities are unrevealing. However, a complex method, inherent variability, and increased binding in regions outside seizure foci will limit applicability. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Tracy Butler; Masanori Ichise; Andrew F Teich; Elizabeth Gerard; Joseph Osborne; Jacqueline French; Orrin Devinsky; Ruben Kuzniecky; Frank Gilliam; Fahad Pervez; Frank Provenzano; Stanley Goldsmith; Shankar Vallabhajosula; Emily Stern; David Silbersweig Journal: J Neuroimaging Date: 2011-01-11 Impact factor: 2.486
Authors: Jussi Hirvonen; William C Kreisl; Masahiro Fujita; Irene Dustin; Omar Khan; Shmuel Appel; Yi Zhang; Cheryl Morse; Victor W Pike; Robert B Innis; William H Theodore Journal: J Nucl Med Date: 2012-01-11 Impact factor: 10.057
Authors: Dario J Englot; Jonathan D Breshears; Peter P Sun; Edward F Chang; Kurtis I Auguste Journal: J Neurosurg Pediatr Date: 2013-06-14 Impact factor: 2.375
Authors: Vera Russmann; Matthias Brendel; Erik Mille; Angela Helm-Vicidomini; Roswitha Beck; Lisa Günther; Simon Lindner; Axel Rominger; Michael Keck; Josephine D Salvamoser; Nathalie L Albert; Peter Bartenstein; Heidrun Potschka Journal: Neuroimage Clin Date: 2017-04-05 Impact factor: 4.881
Authors: Gagandeep Singh; Samuel A Angwafor; Alfred K Njamnshi; Henry Fraimow; Josemir W Sander Journal: Nat Rev Neurol Date: 2020-05-19 Impact factor: 42.937
Authors: Michele Simonato; Denes V Agoston; Amy Brooks-Kayal; Chris Dulla; Brandy Fureman; David C Henshall; Asla Pitkänen; William H Theodore; Roy E Twyman; Firas H Kobeissy; Kevin K Wang; Vicky Whittemore; Karen S Wilcox Journal: Nat Rev Neurol Date: 2021-02-16 Impact factor: 42.937
Authors: William C Kreisl; Min-Jeong Kim; Jennifer M Coughlin; Ioline D Henter; David R Owen; Robert B Innis Journal: Lancet Neurol Date: 2020-11 Impact factor: 44.182
Authors: Jacqueline A French; Andrew J Cole; Edward Faught; William H Theodore; Annamaria Vezzani; Kore Liow; Jonathan J Halford; Robert Armstrong; Jerzy P Szaflarski; Sarah Hubbard; Jagdish Patel; Kun Chen; Wei Feng; Marco Rizzo; Jacob Elkins; Gabrielle Knafler; Kimberly A Parkerson Journal: Neurology Date: 2021-09-14 Impact factor: 9.910
Authors: Ayushe A Sharma; Rodolphe Nenert; Christina Mueller; Andrew A Maudsley; Jarred W Younger; Jerzy P Szaflarski Journal: Front Hum Neurosci Date: 2020-12-23 Impact factor: 3.169